The Agency Inside Harte-Hanks and Alcon Laboratories to

New Post Public Reply Private Reply Replies (0) Message Board
testuser
The Agency Inside Harte-Hanks and Alcon Laboratories to Present at Forrester Marketing Forum

YARDLEY, PA--(Marketwired - Apr 15, 2013) -  The Agency Inside ® Harte-Hanks ( theagencyinside.com ), an omnichannel customer engagement agency of Harte-Hanks ( NYSE : HHS ), announced that it will present the case study Customer Engagement = Loyalty & Revenue with client Alcon Laboratories at the Forrester Forum of Marketing Leaders, in Los Angeles, CA on Friday, April 19, 11:30 a.m. to noon. Julie Collins, director, global digital marketing, Alcon Laboratories and Michele Fitzpatrick, executive vice president, strategy and marketing, The Agency Inside Harte-Hanks, will speak about Alcon's strategic journey and key performance measures as it transformed a single-franchise customer relationship management (CRM) initiative into a full portfolio strategy.

"We are delighted to share the success of our client Alcon Laboratories at Forrester's Forum for Marketing Leaders. Together, we created an interactive CRM program that exceeded revenue and ROI goals by 80%, and provided actionable insights into buyer behavior informing strategic business decisions," said Jeannine Falcone, executive vice president, customer strategy and engagement, Harte-Hanks Direct Marketing, and managing director, The Agency Inside Harte-Hanks. "Alcon's success with this campaign exemplifies the powerful impact fostering an engaging consumer experience can have."

"We worked with The Agency Inside to build customer engagement strategies, measure customer value and manage customer data for our CIBAVision brand. The entire Eyefile™ program was developed on a single digital platform leveraging dynamic content, which enables over 800 different combinations of content and messaging to be delivered cost effectively," said Julie Collins, director, global digital marketing, Alcon Laboratories. "The campaign vaulted from conversion and loyalty to true customer-centric marketing, empowering our customers and prospects with a new and unexpected level of care and connectivity that was the direct result of gaining and applying knowledge and insight about our consumers."

The Agency Inside Harte-Hanks has been named a "Strong Performer" in the Forrester Research, Inc. report, The Forrester Wave™: Customer Engagement Agencies, Q4 2012 (November 2012). Alcon's CIBAVision Eyefile campaign has been recognized as best-in-class across the industry, winning the MM&M Silver Award 2012, Best Use of Direct Marketing to Consumers; Finalist in the Direct Marketing Association Echo Awards; and Philadelphia Direct Marketing Association Benny Award, winner in Broadcast other/Acquisition: Offer to Purchase - Health Care for 2012.

Harte-Hanks will also exhibit at Forrester's Forum for Marketing Leaders at the L.A. LIVE complex in downtown Los Angeles, California adjacent to the Staples Center, 800 W. Olympic Blvd, Los Angeles, CA 90015.

About Alcon Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. The three Alcon businesses -- Surgical, Pharmaceutical and Vision Care -- offer the widest spectrum of eye care products in the world. Alcon is the second largest division of the Novartis Group with pro-forma sales of USD 10.2 billion in 2012. Headquartered in Fort Worth, Texas, U.S.A., Alcon has 24,000 employees worldwide, operations in 75 countries and products available in 180 markets. For more information, visit www.alcon.com .

About Harte-Hanks ® Harte-Hanks, Inc. is a worldwide, direct and targeted marketing company that provides direct marketing services and shopper advertising opportunities to local, regional, national and international consumer and business-to-business marketers. Visit the Harte-Hanks Website at www.harte-hanks.com or call (800) 456-9748.

The Agency Inside Harte-Hanks is a full-service, omnichannel customer engagement agency specializing in direct and digital communications. With award-winning strategy, creative and implementation services, The Agency Inside helps marketers within targeted industries understand, identify, and engage prospects and customers in their channel of choice. Recognized and respected as a market leader for many decades, it is our mission to deploy world-class, insight-driven, multichannel relationship marketing programs that address each client's acquisition, cross-sell, retention and loyalty needs. For more information, visit www.theagencyinside.com .  

This document may contain trademarks that are owned or licensed by Harte-Hanks, Inc. and its subsidiaries, including, without limitation, Harte-Hanks ® and other names and marks. All other brand names, product names, or trademarks belong to their respective holders.

Media Contact: The Agency Inside Harte-Hanks Morayea Pindziak (215) 944-9692 morayea_pindziak@harte-hanks.com

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

53% of European Telecom Users Eye Provider Switch

Updated Category News Views 2

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 1

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 14

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause

Updated Category News Views 0

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading

Top 5 Most Recently Viewed Articles

MongoDB Reports Exceptional Earnings, Boosting Investor Confidence

Updated Category News Views 117

MongoDB's Remarkable Growth Continues MongoDB Inc (NASDAQ: MDB) has become the talk of the town as its shares soar following stellar earnings results that have impressed investors and analysts alike. The recent financial report showcased not just revenue growth but also a promising outlook that has captivated the attention of the market. Investors are keenly watching the...

Continue Reading
Federal Judge's Ruling on Trump's Workforce Watchdog Dismissal

Updated Category News Views 186

Federal Judge's Decision on Trump’s Actions A recent ruling from a federal judge has highlighted the legality of President Donald Trump's dismissal attempts regarding a federal workforce watchdog. This ruling not only affects Trump but also serves as a significant precedent in maintaining the independence of the Office of Special Counsel. Details of the Case Judge Amy...

Continue Reading
Gables Residential Celebrates ESG Commitment with Award Success

Updated Category News Views 188

Gables Residential Earns Esteemed Recognition for ESG Leadership Gables Residential, a recognized leader in the multifamily development and management sector, has achieved a remarkable milestone by receiving the Multi-Housing News (MHN) Excellence Gold Award. This accolade celebrates the company’s dedicated efforts toward Environmental, Social, and Governance (ESG)...

Continue Reading
Microsoft's Layoffs Spark Controversy Over AI Support

Updated Category News Views 221

Layoffs at Microsoft Prompt AI Support Discussion Microsoft Corporation (NASDAQ: MSFT) recently faced a crisis as it laid off approximately 9,100 employees, a move that set off a ripple effect of reactions within the tech community. The company's decision comes as it continues to streamline operations amid economic pressures. In the wake of these layoffs, feedback from an...

Continue Reading
Caris Life Sciences to Present Groundbreaking Research at ESMO 2024

Updated Category News Views 154

Caris Life Sciences to Present Innovative Research at ESMO 2024 Caris Life Sciences (Caris), in partnership with prominent cancer centers, is preparing to unveil significant research findings that highlight the clinical benefits of comprehensive molecular profiling at the European Society for Medical Oncology (ESMO) Congress 2024. The research will cover seven studies...

Continue Reading